Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation
Elizabeth S. Borden, Kenneth H. Buetow, Melissa A. Wilson, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
mRNA: A promising platform for cancer immunotherapy
Byoungjae Kong, Yelee Kim, Eun Hye Kim, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114993-114993
Open Access | Times Cited: 24
The Application of Long-Read Sequencing to Cancer
Luca Ermini, Patrick Driguez
Cancers (2024) Vol. 16, Iss. 7, pp. 1275-1275
Open Access | Times Cited: 9
Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
Paraskevi Vryza, Timo Fischer, Elena Mistakidi, et al.
Translational Oncology (2023) Vol. 38, pp. 101788-101788
Open Access | Times Cited: 15
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Aaron M. Miller, Zeynep Koşaloğlu, Luise Westernberg, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 736
Open Access | Times Cited: 5
Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy
Alla Bulashevska, Zsófia Nacsa, Franziska Lang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective
Qingjuan Wu, Wenliang Lv
IET Nanobiotechnology (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 4
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Weihuan Shao, Yiran Yao, Ludi Yang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
Yuqing Ren, Yi Yue, Xinyang Li, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113147-113147
Closed Access | Times Cited: 4
Designing a multi-neoantigen vaccine for melanoma: Integrating immunoinformatics and biophysics methods
Saba Ismail, Khaled Barakat
Computers in Biology and Medicine (2025) Vol. 190, pp. 110081-110081
Closed Access
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
Simav Gildiz, Tamara Minko
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 123-144
Open Access | Times Cited: 17
Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases
Priyanka S. Rana, James J. Ignatz-Hoover, James J. Driscoll
Cancers (2023) Vol. 15, Iss. 23, pp. 5632-5632
Open Access | Times Cited: 9
Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD
Min Chen, Xin Zhang, Zi‐He Ming, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
The T Cell Receptor β Chain Repertoire of Tumor Infiltrating Lymphocytes Improves Neoantigen Prediction and Prioritization
Thi Mong Quynh Pham, Thành Nhân Nguyễn, Bui Que Tran Nguyen, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 2
Immunotherapy guided precision medicine in solid tumors
Sanjana Mehrotra, Manu Kupani, Jaismeen Kaur, et al.
Advances in protein chemistry and structural biology (2024), pp. 249-292
Closed Access | Times Cited: 2
Prospects and challenges of neoantigen applications in oncology
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access | Times Cited: 2
Solving the puzzle of what makes immunotherapies work
Xiaoxiao Ma, Timothy A. Chan
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 890-900
Open Access | Times Cited: 10
Groundwork for AI: Enforcing a benchmark for neoantigen prediction in personalized cancer immunotherapy
Florian Jaton
Social Studies of Science (2023) Vol. 53, Iss. 5, pp. 787-810
Open Access | Times Cited: 6
Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
BCL2A1 neoepitope–elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer
Shengzhe Lin, Jingwen Hong, Suxin Wu, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 3, pp. 601-610
Closed Access | Times Cited: 1
The T Cell Receptor β Chain Repertoire of Tumor Infiltrating Lymphocytes Improves Neoantigen Prediction and Prioritization
Thi Mong Quynh Pham, Thành Nhân Nguyễn, Bui Que Tran Nguyen, et al.
(2024)
Open Access | Times Cited: 1
Generation of tumor neoantigens by RNA splicing perturbation
Adi Rosenberg-Mogilevsky, Zahava Siegfried, Rotem Karni
Trends in cancer (2024)
Closed Access | Times Cited: 1
Genetically Engineered T Cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
Ana Maria Waaga-Gasser, Thomas Böldicke
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13504-13504
Open Access | Times Cited: 1
Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
Meng Lv, Yan Liu, Wei Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
Esther Cabañas Morafraile, Cristina Sáiz-Ladera, Cristina Nieto‐Jiménez, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 2569-2581
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top